2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow ACCS100: new trials by email Literature Review of ACCS100 trials Research Report on ACCS100
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of ACCS100 to Reduce Aflatoxin Exposure in Kenya ACCS100, Calcium carbonate placebo - Aflatoxicosis | Phase 2 | Completed | Kenya Medical Research Institute | 50 | 2014-08-01 | 2014-09-16 |
| Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100" ACCS100, Placebo - Dietary Carcinogenesis | Phase 2 | Completed | Texas Enterosorbents Incorporated | 234 | 2012-09-01 | 2016-04-19 |
Aflatoxin Poisoning (2) · Neoplasms (1)
Kenya Medical Research Institute (1) · Texas Enterosorbents Incorporated (1)
Kenya (1) · United States (1)
Bradley H Pollock, MPH, Ph.D. (1) · Ellen Yard, PhD (1) · John Vulule, PhD (1) · Johnni Daniel, MPH (1) · Samuel Amwayi, MD (1) · Timothy Philips, PhD (1)